nodes	percent_of_prediction	percent_of_DWPC	metapath
Nandrolone phenpropionate—CYP19A1—semen—cervical cancer	0.216	0.249	CbGeAlD
Nandrolone phenpropionate—AR—semen—cervical cancer	0.191	0.221	CbGeAlD
Nandrolone phenpropionate—CYP19A1—endometrium—cervical cancer	0.0357	0.0412	CbGeAlD
Nandrolone phenpropionate—AR—epithelium—cervical cancer	0.0352	0.0407	CbGeAlD
Nandrolone phenpropionate—AR—uterine cervix—cervical cancer	0.0349	0.0403	CbGeAlD
Nandrolone phenpropionate—AR—decidua—cervical cancer	0.0333	0.0384	CbGeAlD
Nandrolone phenpropionate—CYP19A1—uterus—cervical cancer	0.0329	0.038	CbGeAlD
Nandrolone phenpropionate—AR—renal system—cervical cancer	0.0327	0.0377	CbGeAlD
Nandrolone phenpropionate—AR—endometrium—cervical cancer	0.0316	0.0365	CbGeAlD
Nandrolone phenpropionate—AR—mammalian vulva—cervical cancer	0.0306	0.0353	CbGeAlD
Nandrolone phenpropionate—CYP19A1—female reproductive system—cervical cancer	0.0296	0.0341	CbGeAlD
Nandrolone phenpropionate—AR—uterus—cervical cancer	0.0291	0.0336	CbGeAlD
Nandrolone phenpropionate—CYP19A1—female gonad—cervical cancer	0.0269	0.0311	CbGeAlD
Nandrolone phenpropionate—AR—female reproductive system—cervical cancer	0.0262	0.0302	CbGeAlD
Nandrolone phenpropionate—AR—female gonad—cervical cancer	0.0238	0.0275	CbGeAlD
Nandrolone phenpropionate—AR—vagina—cervical cancer	0.0237	0.0273	CbGeAlD
Nandrolone phenpropionate—CYP19A1—lymph node—cervical cancer	0.0173	0.02	CbGeAlD
Nandrolone phenpropionate—AR—lymph node—cervical cancer	0.0153	0.0177	CbGeAlD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—YY1—cervical cancer	0.0127	0.0952	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—PIAS3—cervical cancer	0.0123	0.0922	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—PIAS3—cervical cancer	0.00984	0.0735	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptors—RARB—cervical cancer	0.00947	0.0707	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—PIAS3—cervical cancer	0.00913	0.0682	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Tryptophan metabolism—UBE3A—cervical cancer	0.00858	0.0641	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—UBE3A—cervical cancer	0.00796	0.0594	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptor transcription pathway—RARB—cervical cancer	0.00748	0.0559	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—UBE3A—cervical cancer	0.00588	0.0439	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—HES1—cervical cancer	0.00434	0.0324	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—MTOR—cervical cancer	0.00329	0.0246	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—NOTCH1—cervical cancer	0.00328	0.0245	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.0026	0.0194	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—cervical cancer	0.00248	0.0186	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—CD4—cervical cancer	0.00245	0.0183	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—CASP8—cervical cancer	0.00242	0.0181	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—STAT3—cervical cancer	0.0019	0.0142	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—CTNNB1—cervical cancer	0.00177	0.0132	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—HES1—cervical cancer	0.00166	0.0124	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—cervical cancer	0.00142	0.0106	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—CTNNB1—cervical cancer	0.00131	0.00975	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—RARB—cervical cancer	0.00129	0.00966	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CASP8—cervical cancer	0.00117	0.00876	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—STAT3—cervical cancer	0.00114	0.0085	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—EGFR—cervical cancer	0.00103	0.00773	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CASP8—cervical cancer	0.00101	0.00754	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000972	0.00726	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—MTOR—cervical cancer	0.000965	0.00721	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CASP3—cervical cancer	0.000888	0.00663	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.000865	0.00646	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—NOTCH2—cervical cancer	0.000856	0.0064	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CTNNB1—cervical cancer	0.000856	0.00639	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.000834	0.00623	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—MTOR—cervical cancer	0.00083	0.0062	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CASP3—cervical cancer	0.000764	0.0057	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—cervical cancer	0.000736	0.0055	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.000735	0.00549	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.000709	0.0053	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—EGFR—cervical cancer	0.000678	0.00506	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—RARB—cervical cancer	0.000622	0.00465	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—cervical cancer	0.000583	0.00436	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—TP53—cervical cancer	0.000569	0.00425	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.000562	0.0042	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—NOTCH1—cervical cancer	0.00053	0.00396	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CA9—cervical cancer	0.00049	0.00366	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—TP53—cervical cancer	0.00049	0.00366	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	0.000472	0.00352	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—NOTCH2—cervical cancer	0.000412	0.00308	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—NOTCH1—cervical cancer	0.000255	0.00191	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—MTHFR—cervical cancer	0.000199	0.00148	CbGpPWpGaD
